{"transactions":[{"id":1198213,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & CORPORATE SECRETARY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T21:11:05.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":278386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":278386,"derivative":{"exercise_price":0.387,"expiration_date":"2035-03-15","underlying":"Common Stock","underlying_shares":278386},"source":{"system":"sec-edgar","filing":"0001415889-25-008441","document":"form4-03182025_090302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588925008441/form4-03182025_090302.xml","form_type":"4"}},{"id":1393608,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & CORPORATE SECRETARY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-02T20:41:45.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on September 1, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.7,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-024433","document":"form4-10022024_081040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588924024433/form4-10022024_081040.xml","form_type":"4"}},{"id":1566987,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & CORPORATE SECRETARY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-19T20:08:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":203000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":203000,"derivative":{"exercise_price":1.5,"underlying":"Common Stock","underlying_shares":203000},"source":{"system":"sec-edgar","filing":"0001415889-24-008487","document":"form4-03192024_080350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588924008487/form4-03192024_080350.xml","form_type":"4"}},{"id":1690552,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corporate Secretary"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:19:50.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-24-000365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919124000365/doc4.xml","form_type":"4"}},{"id":1690551,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corporate Secretary"}}],"security":"Common Stock","published_at":"2024-01-03T21:19:50.000Z","date":"2024-01-02","kind":"sale","planned":false,"acquired":false,"shares":15813,"price":0.91,"value":14389.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."}],"balance_after":45995,"source":{"system":"sec-edgar","filing":"0001209191-24-000365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919124000365/doc4.xml","form_type":"4"}},{"id":1690550,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corporate Secretary"}}],"security":"Common Stock","published_at":"2024-01-03T21:19:50.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,024 shares acquired on May 14, 2021, 531 shares acquired on November 15, 2021, 3,082 shares acquired on May 13, 2022, and 3,967 shares acquired under the 2020 Employee Stock Purchase Plan."}],"balance_after":61808,"source":{"system":"sec-edgar","filing":"0001209191-24-000365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919124000365/doc4.xml","form_type":"4"}},{"id":1924473,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corporate Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T23:27:52.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":1.08,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-023477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919123023477/doc4.xml","form_type":"4"}},{"id":2117330,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corporate Secretary"}}],"security":"Restricted Stock Unit","published_at":"2022-11-14T21:22:14.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-056611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122056611/doc4.xml","form_type":"4"}},{"id":2231015,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO, GC & Corp. Sec."}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-15T21:22:24.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":106000,"derivative":{"exercise_price":2.29,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001209191-22-037051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122037051/doc4.xml","form_type":"4"}},{"id":2248965,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO, GC & Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-01T20:17:46.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.8,"expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-033149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122033149/doc4.xml","form_type":"4"}},{"id":2396935,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T21:47:28.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":106000,"derivative":{"exercise_price":4.52,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001787297-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000178729722000001/primary_doc.xml","form_type":"4"}},{"id":2848607,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T00:27:33.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":170997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":170997,"derivative":{"exercise_price":21.85,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":170997},"source":{"system":"sec-edgar","filing":"0001209191-21-012158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919121012158/doc4.xml","form_type":"4"}},{"id":3230353,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Common Stock","published_at":"2020-03-03T23:35:09.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":2000,"price":18,"value":36000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-20-015618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919120015618/doc4.xml","form_type":"4"}},{"id":3237021,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":81793,"kind":"person","name":"Cale Edgar B.","position":1,"cik":"0001799783","reported_name":"Cale Edgar B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-02T22:52:21.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":99731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":99731,"derivative":{"exercise_price":18,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":99731},"source":{"system":"sec-edgar","filing":"0001209191-20-014694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919120014694/doc4.xml","form_type":"4"}}]}